Imaging technology in the diagnosis of hepatic fibrosis.
影像学技术在诊断肝纤维化中的应用。
Objective: To study the effects of 919 syrup on hepatic fibrosis.
目的：研究919糖浆抗肝纤维化的作用。
Objective To assess the morphology of liver in hepatic fibrosis by ct and MR.
目的评价肝纤维化患者肝脏形态学改变CT、MR表现。
Objective To discuss the histological quantitative method of hepatic fibrosis.
目的探讨肝纤维化组织学量化诊断方法。
Objective: To investigate the anti-hepatic fibrosis action of Ganlekang Capsule.
目的：研究肝乐康胶囊抗肝纤维化的作用。
Objective: To study the effect of taurine on experimental hepatic fibrosis in rats.
目的：研究牛磺酸对大鼠实验性肝纤维化的影响。
Objective To investigate the effect of rhein on the development of hepatic fibrosis.
目的观察大黄酸对肝纤维化形成的影响。
Objective to study the relation of hepatic fibrosis indexes to clinic and pathology.
目的了解血清肝纤维化指标与临床及病理的关系。
ObjectiveTo explore the anti-hepatic fibrosis mechanisms of salvianolic acid B (SA-B).
目的探讨丹参酚酸B（SA-B）抗肝纤维化作用机制。
CONCLUSION Ganzhifu can protect liver and prevent or alleviate the rats hepatic fibrosis.
结论肝之福可保护肝脏，预防或缓解肝纤维化的形成。
Hepatic fibrosis; Decoction; Hyaluronic acid; Precollagen; Collogen; Liver function test.
肝硬化；汤剂；胶原；前胶原；透明质酸；肝功能试验。
Therapeutic effects of total glucosides of paeony on rats with immunological hepatic fibrosis.
该研究表明白芍总苷可以减缓小鼠免疫性肝纤维化；
Objective to research and to compare the effects of several vitamin on rats with hepatic fibrosis.
目的研究几种维生素对肝纤维化大鼠的影响并比较其疗效。
Objective To investigate the relationship between hepatic fibrosis and hepatic stellate cell (HSC).
目的研究肝星状细胞(HSC)与肝纤维化和肝硬化的关系。
There was a positive correlation between the pathology grade and stage with hepatic fibrosis indexes.
慢性肝炎患者肝脏病理分级分期与血清肝纤维化指标存在相关性。
AIM: To investigate the therapeutic effects and mechanism of thalidomide on hepatic fibrosis in rats.
目的：观察沙利度胺对大鼠实验性肝纤维化的治疗效果并探讨其作用机制。
Objective To evaluate the clinical value of serum fibrosis index in the diagnosis of hepatic fibrosis.
目的明确肝纤维化血清学指标对诊断肝纤维化的临床价值。
The main mechanism of the interfering effects of Ruanganhuazheng Pills (RP) on hepatic fibrosis was studied.
观察软肝化疒征丸干预肝纤维化的主要作用机制。
SR reduces the rate of hepatic fibrosis and other disease-related complications and, in turn, increases HRQL.
SR减少肝纤维变性和其他与疾病相关的复杂化的几率，并且改善病人生活质量。
SVR reduces the rate of hepatic fibrosis and other disease-related complications and, in turn, increases HRQL.
SVR减少肝纤维变性和其他与疾病相关的复杂化的几率，并且改善病人生活质量。
The imaging data and related parameters were statistically analyzed according to the staging of hepatic fibrosis.
根据纤维化程度分期进行影像资料和相关指标的统计分析。
Objective to probe into the inhibiting action of Compound Biejiarangan Troche on alcohol hepatic fibrosis in rats.
目的探讨复方鳖甲软肝片对实验性大鼠酒精性肝纤维化的抑制作用及机制。
The surrounding liver tissue either in cirrhosis or in hepatic fibrosis appeared normal hepatic enzymatic activity.
而癌周肝组织无论是肝硬化或肝纤维化均显示正常肝细胞的酶活性。
Conclusions HCI and SOS are helpful to assess liver reserve function and hepatic bone strength in hepatic fibrosis.
结论超声检测hci及SOS，对慢性肝病时肝储备功能和骨骼强度的评估具有积极作用。
Methods By comparing the influential factors in 50 patients with hepatic fibrosis and those without who lived nearby.
方法对50例肝纤维化患者和患者住地附近非肝纤维化者作病例对照研究。
Objective: To investigate the inhibitive effects of safflower on experimental hepatic fibrosis in rats and its mechanism.
目的：观察红花对实验性大鼠肝纤维化的影响，并探讨其作用机制。
Portal venous pressure and gallbladder wall thickness were measured by ultrasound on different stages of hepatic fibrosis.
目的探讨超声检测肝纤维化胆囊壁厚度与门静脉压力变化的关系。
Objective To observe the clinical effect of both oxymatrine and lamivudine on hepatic fibrosis induced by chronic hepatitis b.
目的观察拉米夫定联合氧化苦参碱对抗慢性乙型肝炎(乙肝)肝纤维化的临床疗效。
Conclusions Ultrasonographic quantitative score system has higher clinical value for noninvasive diagnosis of hepatic fibrosis.
结论应用超声评分法无创诊断肝纤维化有较高的临床价值。
Objective To study changes of hepatic circulation index (HCI) and bone strength in experimental hepatic fibrosis with ultrasound.
目的探讨超声检测实验性肝纤维化肝循环指数(HCI)及骨强度的作用。
应用推荐